Abstract:Background: The optimal lymphadenectomy approach for solid-dominant stage I non-small-cell lung cancer (NSCLC) is controversial. The present study aimed to compare the survival outcomes following lobectomy with different varieties of lymphadenectomy in patients with solid-dominant stage I NSCLC.Methods: Patients diagnosed with solid-dominant stage I NSCLC from 2008 to 2015 were included and grouped according to the mode of lymphadenectomy. Disease-free survival (DFS) and overall survival (OS) were compared, and univariate survival analysis was performed among groups. Cox analysis was used to identify independent prognostic factors. Nomograms for survival prediction based on lymphadenectomy mode were constructed and internally calibrated. Propensity score matching (PSM) was used to balance the potential confounders. After PSM, subgroup comparisons between bilateral mediastinal lymphadenectomy (BML), systematic nodal dissection (SND), lobe-specific lymph node dissection (LSND) and systematic nodal sampling (SNS) were conducted.Findings: In total, 983 patients were included. The 5-year OS rates were 98.2%, 86.9%, 86.4%, 82.8% (p=0.006), and the 5-year DFS rates were 87.1%, 76.4%, 69.5%, 70.9% (p=0.008) in the BML, SND, LSND and SNS groups, respectively. Compared with SNS, BML was independently associated with better OS and DFS. After PSM, patients who underwent BML showed better OS (HR, 0.358; 95% CI, 0.127-1.008; p=0.052) and DFS (HR, 0.563; 95% CI 0.295-1.074; p=0.081) than those who underwent SND, with marginal significance. Compared with L-SND and SNS, BML was associated with significantly improved OS (HR, 0.343; 95% CI 0.123-0.958; p=0.041 and HR, 0.250; 95% CI 0.088-0.709; p=0.009, respectively) and DFS (HR, 0.474; 95% CI 0.258-0.868; p=0.016 and HR, 0.467; 95% CI 0.232-0.938; p=0.032, respectively). Subgroup analyses demonstrated that for male patients and those whose tumors were larger or more advanced, BML was associated with significantly better OS and DFS than other types of lymphadenectomy.Interpretation: In patients with solid-dominant stage I NSCLC, BML might be associated with better survival and is recommended for these patients, especially those with large tumors.Funding Information: This study was supported by the grant from the National Key R&D Program of China (2016YFC0905400).Declaration of Interests: The authors declare no conflicts of interest in this work.Ethics Approval Statement: This study was approved by the Institutional Review Board of Sun Yat-sen University Cancer Center (B2018-011) and the Medical Ethics Committee of the First Affiliated Hospital, School of Medicine, Zhejiang University (2013-255-1).

Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules

Subsolid Lung Adenocarcinomas: Radiological, Clinical and Pathological Features and Outcomes.

Distinct Prognostic Factors in Patients with Stage I Non–Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions

A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodules.

Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers

Prognostic Value of Preoperative N Subcategories in Patients with Stage IIIA N2 Non-Small Cell Lung Cancer

Role of Pathologic Single-N and Multiple-N Descriptors in Resected Non-Small Cell Lung Cancer

Differential Diagnosis of Nonabsorbable Inflammatory and Malignant Subsolid Nodules with a Solid Component ≤5 mm

Bilateral Mediastinal Lymphadenectomy is Associated with Potential Survival Advantages in Patients with Solid-Dominant Stage I Non-Small-Cell Lung Cancer Who Underwent Anatomic Lung Resection

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Meta-analysis of Comparing Part-Solid and Pure-Solid Tumors in Patients with Clinical Stage IA Non-Small-cell Lung Cancer in the Eighth Edition TNM Classification

Subsolid Lesions Exceeding 3 Centimeters: The Ground-Glass Opacity Component Still Matters

Disparate genomic characteristics of patients with early-stage lung adenocarcinoma manifesting as radiological subsolid or solid lesions

Tumor Size As a Predictor for Prognosis of Patients with Surgical IIIA-N2 Non-Small Cell Lung Cancer after Surgery.

Lung Adenocarcinomas Manifesting As Radiological Part-Solid Nodules Define a Special Clinical Subtype.

The Prognostic and Predictive Value of Solid Subtype in Invasive Lung Adenocarcinoma

Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?

Radiographical consolidation tumor size and preoperative clinical characteristics are significantly correlated with the postoperative survival of patients with part-solid and pure-solid adenocarcinomas: a propensity score-matched analysis

An Effective Malignancy Prediction Model for Incidentally Detected Pulmonary Subsolid Nodules Based on Current and Prior CT Scans.

Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer

Natural history of pathologically confirmed pulmonary subsolid nodules with deep learning–assisted nodule segmentation